{"disease":{"id":"horton-s-disease","name":"horton s disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04390126","title":"COVID-19 Related Lockdown Effects On Chronic Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":1343,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT02065297","title":"Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)","phase":"","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT02857192","title":"Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT02158208","title":"Study of the T CD8 Immune Response in Horton's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT02955147","title":"Ustekinumab for the Treatment of Giant Cell Arteritis","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}